维多利亚的秘密 VSCO 深 沪
等待开盘 12-18 09:30:00 美东时间
53.07
-0.590
-1.10%
华盛通- 最 高55.8291
- 今 开54.945
- 成交量 168.60万股
- 最 低 52.83
- 昨 收 53.66
- 总市值 42.38亿
- 52周最高 56.33
- 市盈率 静 26.05
- 换手率 2.11%
- 52周最低 13.76
- 委 比 0.00%
- 总股本 7985.25万
- 历史最高 76.00
- 量 比 0.55
- 振 幅 5.59%
- 历史最低 13.62
- 每 手 1
- 风险率 9.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
Shares of broader consumer discretionary stocks are trading higher, possibly due to a rotation out of tech names.
Shares of broader consumer discretionary stocks are trading higher, possibly du...
12-13 04:07
华尔街顶级分析师最新评级：亚马逊获首次覆盖、通用电气能源升级
华尔街最受热议且影响市场的分析师研报评级如今汇总于此。以下是由 The Fly 整理的、投资者需关注的今日研报评级。 五大评级上调 奥本海默将通用电气能源...
12-10 23:12
Guggenheim Initiates Coverage On Victoria's Secret with Neutral Rating
Guggenheim analyst Simeon Siegel initiates coverage on Victoria's Secret (NYSE:VSCO) with a Neutral rating.
12-10 19:36
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
12-08 08:34
美股牛股 | SMX 隔夜飙涨135.4%，DigitalBridge隔夜大涨45.3%
SMX (Security Matters) Public Ltd Co Ordinary Shares - Class A涨135.4%；DigitalBridge Group涨45.3%；Toro Corp. - Common stock涨40.4%
12-06 08:28
Highly Short Stock Victoria Secret Rallies On Strong Q3 Performance
Victoria's Secret & Co. (NYSE: VSCO) reported third-quarter results with net sales of $1.472 billion, up 9% from last year, and raised full-year guidance.
12-06 00:10
Victoria's Secret Sees Q4 Adj EPS $2.20-$2.45 vs $2.23 Est; Sees Sales $2.170B-$2.200B vs $2.171B Est
Victoria's Secret (NYSE:VSCO) is looking for Q4 Adj EPS of $2.20-$2.45 vs $2.23 analyst estimate. sees sales of $2.170 billion-$2.200 billion vs $2.171 billion analyst estimate.
12-05 20:02
Victoria's Secret Q3 Adj. EPS $(0.27) Beats $(0.59) Estimate, Sales $1.472B Beat $1.410B Estimate
Victoria's Secret (NYSE:VSCO) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.59) by 54.08 percent. This is a 46 percent increase over losses of $(0.50) per share from the
12-05 20:01
